You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 9,410,138

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,410,138

Title:	Asparaginase from basidiomycetes
Abstract:	An asparaginase enzyme derived from the fungi Basidiomycete, in particular the Basidiomycete is Flammulina velutipes. A method for hydrolysing at least one of L-asparagine or L-glutamine. A method for reducing acrylamide formation in a substance comprising L-asparagine is also described.
Inventor(s):	Berends; Pieter (Zoznegg-muhlingen, DE), Rabe; Swen (Muehlingen, DE), Berger; Ralf Gunter (Hannover, DE), Linke; Diana (Bad Rehburg, DE), Eisele; Nadine (Kufstein, AT)
Assignee:	Nestec S.A. (Vevey, CH)
Application Number:	14/477,448
Patent Claims:	1. A method for hydrolyzing at least one of L-asparagine or L-glutamine, the method comprising: treating a substance comprising at least one of L-asparagine or L-glutamine with an asparaginase enzyme comprising the amino acid sequence of SEQ ID NO: 1, thereby hydrolyzing said at least one of L-asparagine or L-glutamine; and inactivating said asparaginase enzyme by thermal treatment of said substance. 2. The method of claim 1, wherein said substance comprising at least one of L-asparagine or L-glutamine is at least one of a human consumable product or an animal consumable product. 3. The method of claim 1, wherein said substance is selected from the group consisting of beverages, cocoa beans, cheese, coffee beans, confectionary, desserts, dough, dressing, French fries, drinks, meat products, medical supplements, nutritional supplements, pet food, potato chips, sauces, snack and soups. 4. A method for reducing acrylamide formation in a food substance comprising L-asparagine, said method comprising: contacting said food substance comprising L-asparagine with an as asparaginase enzyme comprising the amino acid sequence of SEQ ID NO: 1, thereby reducing acrylamide formation in said food substance; and inactivating said asparaginase enzyme by thermal treatment of said food substance.

Details for Patent 9,410,138

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978	⤷ Try a Trial	2030-07-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.